Какова цена за Hancock Jaffe Laboratories (HJLI)

Цена за Hancock Jaffe Laboratories (HJLI) Это $10.38

Какова рыночная капитализация для Hancock Jaffe Laboratories (HJLI)

Рыночная капитализация для Hancock Jaffe Laboratories (HJLI) Это $4.55M

Hancock Jaffe Laboratories (HJLI) Коэффициент P/S

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Год	P/S	Изменить
Недостаточно данных для указанных дат.

Год

P/S

Изменить

Недостаточно данных для указанных дат.

Компания	P/S	Разница P/S	Страна
Abbott Laboratories ABT.US	4.13	-	US
Stryker Corporation SYK.US	5.03	-	US
Medtronic plc MDT.US	2.78	-	IE
Boston Scientific Corporation BSX.US	3.67	-	US
Edwards Lifesciences Corporation EW.US	8.10	-	US

Компания

P/S

Разница P/S

Страна